Elsevier

World Neurosurgery

Volume 82, Issue 6, December 2014, Pages 929-931
World Neurosurgery

News
Operative Cytoreduction for Recurrent Glioblastoma

https://doi.org/10.1016/j.wneu.2014.10.004Get rights and content

First page preview

First page preview
Click to open first page preview

References (9)

  • M.E. Hegi et al.

    Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity

    J Clin Oncol

    (2008)
  • M. Lacroix et al.

    A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

    J Neurosurg

    (2001)
  • E.R. Laws et al.

    Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project

    J Neurosurg

    (2003)
  • M.E. Oppenlander et al.

    An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity

    J Neurosurg

    (2014)
There are more references available in the full text version of this article.

Cited by (0)

View full text